Neuroleptic drugs in the treatment of tuberculosis: Minimal inhibitory concentrations of different phenothiazines against Mycobacterium tuberculosis

Tuberculosis

Volumn 98, Issue , 2016, Pages 27-29

  Vesenbeckh, Silvan ^a   Krieger, David ^a   Bettermann, Gudrun ^a   Schönfeld, Nicolas ^a   Bauer, Torsten Thomas ^a,b   Rüssmann, Holger ^a   Mauch, Harald ^a  

^a HELIOS KLINIKUM EMIL VON BEHRING   (Germany)

^b Deutsches Zentralkomitee Zur Bekämpfung der Tuberkulose E â Scaron V DZK   (Germany)

Author keywords

Antibiotic resistance; Drug development; Efflux pump; Guideline; Public health

Indexed keywords

PHENOTHIAZINE DERIVATIVE; THIORIDAZINE; NEUROLEPTIC AGENT; TUBERCULOSTATIC AGENT;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; CONTROLLED STUDY; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; TUBERCULOSIS; COMPARATIVE STUDY; DRUG EFFECTS; DRUG REPOSITIONING; EXTENSIVELY DRUG-RESISTANT TUBERCULOSIS; GENETICS; GENOTYPE; GROWTH, DEVELOPMENT AND AGING; HUMAN; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MULTIDRUG RESISTANCE; PATHOGENICITY; PHENOTYPE; TUBERCULOSIS, MULTIDRUG-RESISTANT;

ANTIPSYCHOTIC AGENTS; ANTITUBERCULAR AGENTS; DRUG REPOSITIONING; DRUG RESISTANCE, MULTIPLE, BACTERIAL; EXTENSIVELY DRUG-RESISTANT TUBERCULOSIS; GENOTYPE; HUMANS; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM TUBERCULOSIS; PHENOTHIAZINES; PHENOTYPE; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 84960116119     PISSN: 14729792     EISSN: 1873281X     Source Type: Journal    
DOI: 10.1016/j.tube.2016.02.003     Document Type: Article

References (16)

1. N. Alsaad, B. Wilffert, R. van Altena, W.C. de Lange, T.S. van der Werf, J.G. Kosterink, and J.W. Alffenaar Potential antimicrobial agents for the treatment of multidrug-resistant tuberculosis Eur Respir J 43 2014 884 897 10.1183/09031936.00113713
2. T. Burki Improving the health of the tuberculosis drug pipeline Lancet Infect Dis 14 2014 102 103
3. S. Sharma, and A. Singh Phenothiazines as anti-tubercular agents: mechanistic insights and clinical implications Expert Opin Invest Drugs 20 2011 1665 1676 10.1517/13543784.2011.628657
4. A.J. Crowle, G.S. Douvas, and M.H. May Chlorpromazine: a drug potentially useful for treating mycobacterial infections Chemotherapy 38 1992 410 419
5. D. Ordway, M. Viveiros, C. Leandro, R. Bettencourt, J. Almeida, M. Martins, J.E. Kristiansen, J. Molnar, and L. Amaral Clinical concentrations of thioridazine kill intracellular multidrug-resistant Mycobacterium tuberculosis Antimicrob Agents Chemother 47 2003 917 922
6. K. Hartigan-Go, D.N. Bateman, G. Nyberg, E. Martensson, and S.H. Thomas Concentration-related pharmacodynamic effects of thioridazine and its metabolites in humans Clin Pharmacol Ther 60 1996 543 553 10.1016/S0009-9236(96)90150-2
7. F. Moriya, and Y. Hashimoto Redistribution of basic drugs into cardiac blood from surrounding tissues during early-stages postmortem J forensic Sci 44 1999 10 16
8. D. van Soolingen, R. Hernandez-Pando, H. Orozco, D. Aguilar, C. Magis-Escurra, L. Amaral, J. van Ingen, and M.J. Boeree The antipsychotic thioridazine shows promising therapeutic activity in a mouse model of multidrug-resistant tuberculosis PLoS One 5 2010 10.1371/journal.pone.0012640
9. L. Amaral, M.J. Boeree, S.H. Gillespie, Z.F. Udwadia, and D. van Soolingen Thioridazine cures extensively drug-resistant tuberculosis (XDR-TB) and the need for global trials is now! Int J Antimicrob Agents 35 2010 524 526 10.1016/j.ijantimicag.2009.12.019
10. E. Abbate, M. Vescovo, M. Natiello, M. Cufre, A. Garcia, P. Gonzalez Montaner, M. Ambroggi, V. Ritacco, and D. van Soolingen Successful alternative treatment of extensively drug-resistant tuberculosis in Argentina with a combination of linezolid, moxifloxacin and thioridazine J Antimicrob Chemother 67 2012 473 477 10.1093/jac/dkr500
11. N. Schonfeld, T. Bergmann, S. Vesenbeckh, H. Mauch, G. Bettermann, T.T. Bauer, and H. Russmann Minimal inhibitory concentrations of first-line drugs of multidrug-resistant tuberculosis isolates Lung India 29 2012 309 312 10.4103/0970-2113.102794
12. M. Martins, Z. Schelz, A. Martins, J. Molnar, G. Hajos, Z. Riedl, M. Viveiros, I. Yalcin, E. Aki-Sener, and L. Amaral In vitro and ex vivo activity of thioridazine derivatives against Mycobacterium tuberculosis Int J Antimicrob Agents 29 2007 338 340 10.1016/j.ijantimicag.2006.10.013
13. M.J. Advani, I. Siddiqui, P. Sharma, and H. Reddy Activity of trifluoperazine against replicating, non-replicating and drug resistant M. tuberculosis PLoS One 7 2012 e44245 10.1371/journal.pone.0044245
14. M. Viveiros, and L. Amaral Enhancement of antibiotic activity against poly-drug resistant Mycobacterium tuberculosis by phenothiazines Int J Antimicrob Agents 17 2001 225 228
15. A. Singh, and S. Sharma Chemotherapeutic efficacy of thioridazine as an adjunct drug in a murine model of latent tuberculosis Tuberculosis 94 2014 695 700 10.1016/j.tube.2014.08.016
16. A.H. Glassman, and J.T. Bigger Jr. Antipsychotic drugs: prolonged QTc interval, torsade de pointes, and sudden death Am J psychiatry 158 2001 1774 1782